4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-23-065259
Co-Chief Executive Officer acquired 63,694 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2023-11-16 | Option exercise | +63,694 | $1.57 | $100,000 | 2,906,311 | D |
| Derivatives | |||||||
| Cohen Joshua B Co-Chief Executive Officer | 2023-11-16 | Option exercise · Stock Option (Right to Buy) | −63,694 | 36,306 | D | ||
Loading xslF345X05/ownership.xml…